product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
PU.1 Antibody
catalog :
2266
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, chromatin immunoprecipitation, immunohistochemistry - paraffin section
citations: 12
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; human; 1:100; fig 6
Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed publisher
  • western blot; mouse; fig 1
Karpurapu M, Ranjan R, Deng J, Chung S, Lee Y, Xiao L, et al. Krüppel like factor 4 promoter undergoes active demethylation during monocyte/macrophage differentiation. PLoS ONE. 2014;9:e93362 pubmed publisher
Krogmann A, Lüsebrink E, Steinmetz M, Asdonk T, Lahrmann C, Lütjohann D, et al. Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice. PLoS ONE. 2016;11:e0146326 pubmed publisher
Wu J, Pinello L, Yissachar E, Wischhusen J, Yuan G, Roberts C. Functionally distinct patterns of nucleosome remodeling at enhancers in glucocorticoid-treated acute lymphoblastic leukemia. Epigenetics Chromatin. 2015;8:53 pubmed publisher
Wang E, Kawaoka S, Roe J, Shi J, Hohmann A, Xu Y, et al. The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer. elife. 2015;4:e06377 pubmed publisher
Bernard M, Han X, Inderbitzin S, Agbim I, Zhao H, Koziel H, et al. HIV-derived ssRNA binds to TLR8 to induce inflammation-driven macrophage foam cell formation. PLoS ONE. 2014;9:e104039 pubmed publisher
Gu X, Hu Z, Ebrahem Q, Crabb J, Mahfouz R, Radivoyevitch T, et al. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy. J Biol Chem. 2014;289:14881-95 pubmed publisher
Swindell W, Johnston A, Xing X, Little A, Robichaud P, Voorhees J, et al. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Sci Rep. 2013;3:1215 pubmed publisher
Horiuchi M, Wakayama K, Itoh A, Kawai K, Pleasure D, Ozato K, et al. Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia. J Neuroinflammation. 2012;9:227 pubmed publisher
Barberi T, Dunkle A, He Y, Racioppi L, Means A. The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice. PLoS ONE. 2012;7:e29808 pubmed publisher
Shalhoub J, Falck Hansen M, Davies A, Monaco C. Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm (Lond). 2011;8:9 pubmed publisher
Foxler D, James V, Shelton S, Vallim T, Shaw P, Sharp T. PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1. FEBS Lett. 2011;585:1089-96 pubmed publisher
product information
SKU :
2266S
Product-Name :
PU.1 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, (Mk, Pg)
Applications :
Chromatin Immunoprecipitation
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
42
Host :
Rabbit
Target :
PU.1
Primary-Protein :
PU.1
Alt-Names :
31 kDa transforming protein,31 kDa-transforming protein,OF,PU.1,SFPI1,SPI-1,SPI-1 proto-oncogene,SPI-A,SPI1,Transcription factor PU.1,hematopoietic transcription factor PU.1,spleen focus forming virus (SFFV) proviral integration oncogene spi1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.